Emcure Pharmaceuticals receives SEBI nod for its IPO launch

Emcure Pharmaceuticals received SEBI nod for IPO launch after filing DRHP in December 2023. The IPO includes equity shares and an Offer of Sale by promoters. Proceeds will be used for debt payment. Emcure Pharmaceuticals is renowned for its global marketing of pharmaceutical products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/64XkCq5
via IFTTT